Zosano Pharma Corp. says unsecured creditors owed $12.3 million in its chapter 11 bankruptcy liquidation are expected to recoup 28% of what they are owed.
The publicly traded Fremont, Calif.-based company made the disclosure Thursday in the U.S. Bankruptcy Court in Wilmington, Del.
Earlier this month, the court approved the sale of most of its assets to Emergex Vaccines.
The company, which was spun off in 2006 from a Johnson & Johnson subsidiary, struggled since the Food and Drug Administration rejected its application seeking approval for its M207 transdermal migraine patch in late 2020.
Write to Becky Yerak at becky.yerak@wsj.com
$(END)$ Dow Jones Newswires
August 26, 2022 13:26 ET (17:26 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。